Mandewale MC, Patil UC, Shedge SV, Dappadwad UR, Yamgar RS. A review on quinoline hydrazone derivatives as a new class of potent antitubercular and anticancer agents. Beni-Suef University J Basic App Sci. 2017;6(4):354–61.
Article
Google Scholar
Vitaku E, Smith DT, Njardarson JT. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among US FDA approved pharmaceuticals: miniperspective. J Med Chem. 2014;57(24):10257–74.
Article
CAS
Google Scholar
Lohrer B, Bracher F. A short and divergent route to 2-alkenyl-4-quinolones. Tetrahedron Lett. 2018;59(40):3632–5.
Article
CAS
Google Scholar
Lin H, Dai C, Jamison TF, Jensen KF. A rapid total synthesis of ciprofloxacin hydrochloride in continuous flow. Angew Chem Int Ed. 2017;56(30):8870–3.
Article
CAS
Google Scholar
Bai H, Liu F, Wang X, Wang P, Huang C. Three-Component one-pot approach to highly efficient and sustainable synthesis of the functionalized quinolones via linear/branched domino protocols, key synthetic methods for the Floxacin of Quinolone Drugs. ACS Omega. 2018;3(9):11233–51.
Article
CAS
Google Scholar
Naeem A, Badshah SL, Muska M, Ahmad N, Khan K. The current case of quinolones: synthetic approaches and antibacterial activity. Molecules. 2016;21(4):268.
Article
Google Scholar
Boteva A, Krasnykh O. The methods of synthesis, modification, and biological activity of 4-quinolones. Chem Heterocycl Compd. 2009;45(7):757–85.
Article
CAS
Google Scholar
Xu X, Sun R, Zhang S, Zhang X, Yi W. Divergent synthesis of quinolones and dihydroepindolidiones via Cu (I)-catalyzed cyclization of anilines with alkynes. Org Lett. 2018;20(7):1893–7.
Article
CAS
Google Scholar
Wube A, Guzman J-D, Hüfner A, Hochfellner C, Blunder M, Bauer R, et al. Synthesis and antibacterial evaluation of a new series of N-Alkyl-2-alkynyl/(E)-alkenyl-4-(1H)-quinolones. Molecules. 2012;17(7):8217–40.
Article
CAS
Google Scholar
Dayam R, Al-Mawsawi LQ, Zawahir Z, Witvrouw M, Debyser Z, Neamati N. Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitors. J Med Chem. 2008;51(5):1136–44.
Article
CAS
Google Scholar
Asahina Y, Araya I, Iwase K, Iinuma F, Hosaka M, Ishizaki T. Synthesis and antibacterial activity of the 4-quinolone-3-carboxylic acid derivatives having a trifluoromethyl group as a novel N-1 substituent. J Med Chem. 2005;48(9):3443–6.
Article
CAS
Google Scholar
Lucero BdA, Gomes CRB, de Frugulhetti ICPP, Faro LV, Alvarenga L, de Souza MCB, et al. Synthesis and anti-HSV-1 activity of quinolonic acyclovir analogues. Bioorg Med Chem Lett. 2006;16(4):1010–3.
Article
CAS
Google Scholar
Alsayed SS, Lun S, Luna G, Beh CC, Payne AD, Foster N, et al. Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents. RSC Adv. 2020;10(13):7523–40.
Article
CAS
Google Scholar
Zhang Z, Xiao X, Su T, Wu J, Ren J, Zhu J, et al. Synthesis, structure-activity relationships and preliminary mechanism of action of novel water-soluble 4-quinolone-3-carboxamides as antiproliferative agents. Eur J Med Chem. 2017;140:239–51.
Article
CAS
Google Scholar
Sabbah DA, Haroon RA, Bardaweel SK, Hajjo R, Sweidan K. N-phenyl-6-chloro-4-hydroxy-2-quinolone-3-carboxamides: molecular docking, synthesis, and biological investigation as anticancer agents. Molecules. 2020;26(1):73.
Article
Google Scholar
Tan L, Zhang Z, Gao D, Luo J, Tu Z-C, Li Z, et al. 4-Oxo-1, 4-dihydroquinoline-3-carboxamide derivatives as new Axl kinase inhibitors. J Med Chem. 2016;59(14):6807–25.
Article
CAS
Google Scholar
Pasquini S, Ligresti A, Mugnaini C, Semeraro T, Cicione L, De Rosa M, et al. Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure—affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands. J Med Chem. 2010;53(16):5915–28.
Article
CAS
Google Scholar
Mugnaini C, Brizzi A, Ligresti A, Allarà M, Lamponi S, Vacondio F, et al. Investigations on the 4-quinolone-3-carboxylic acid motif. 7. Synthesis and pharmacological evaluation of 4-quinolone-3-carboxamides and 4-hydroxy-2-quinolone-3-carboxamides as high affinity cannabinoid receptor 2 (CB2R) ligands with improved aqueous solubility. J Med Chem. 2016;59(3):1052–67.
Article
CAS
Google Scholar
Kapale SS, Mali SN, Chaudhari HK. Molecular modelling studies for 4-oxo-1, 4-dihydroquinoline-3-carboxamide derivatives as anticancer agents. Med Drug Discovery. 2019;2:100008.
Article
Google Scholar
Forezi LdS, Tolentino N, De Souza AM, Castro HC, Montenegro RC, Dantas RF, et al. Synthesis, cytotoxicity and mechanistic evaluation of 4-oxoquinoline-3-carboxamide derivatives finding new potential anticancer drugs. Molecules. 2014;19(5):6651–70.
Article
Google Scholar
Balasubramanian G, Kilambi N, Rathinasamy S, Rajendran P, Narayanan S, Rajagopal S. Quinolone-based HDAC inhibitors. J Enzyme Inhib Med Chem. 2014;29(4):555–62.
Article
CAS
Google Scholar
de Forezi LSM, Ribeiro MM, Marttorelli A, Abrantes JL, Rodrigues CR, Castro HC, et al. Design, synthesis, in vitro and in silico studies of novel 4-oxoquinoline ribonucleoside derivatives as HIV-1 reverse transcriptase inhibitors. European J Med Chem. 2020;194:112255.
Article
CAS
Google Scholar
Reddy GV, Kanth SR, Maitraie D, Narsaiah B, Rao PS, Kishore KH, et al. Design, synthesis, structure–activity relationship and antibacterial activity series of novel imidazo fused quinolone carboxamides. Eur J Med Chem. 2009;44(4):1570–8.
Article
Google Scholar
Batalha PN, da Forezi LSM, Freitas MCR, Tolentino NMdC, Orestes E, Carneiro JWdM, et al. Study on the regioselectivity of the N-ethylation reaction of N-benzyl-4-oxo-1, 4-dihydroquinoline-3-carboxamide. Beilstein J Org Chem. 2019;15(1):388–400.
Article
CAS
Google Scholar
Santos FdC, Abreu P, Castro HC, Paixão IC, Cirne-Santos CC, Giongo V, et al. Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives. Bioorg Med Chem. 2009;17(15):5476–81.
Article
CAS
Google Scholar
Harrington PE, Croghan MD, Fotsch C, Frohn M, Lanman BA, Pennington LD, et al. Optimization of a potent, orally active S1P1 agonist containing a quinolinone core. ACS Med Chem Lett. 2012;3(1):74–8.
Article
CAS
Google Scholar
Mesiti F, Maruca A, Silva V, Rocca R, Fernandes C, Remião F, et al. 4-Oxoquinolines and monoamine oxidase: when tautomerism matters. Eur J Med Chem. 2021;213:113183.
Article
CAS
Google Scholar
Stern E, Muccioli GG, Millet R, Goossens J-F, Farce A, Chavatte P, et al. Novel 4-oxo-1, 4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling. J Med Chem. 2006;49(1):70–9.
Article
CAS
Google Scholar
Stern E, Muccioli GG, Bosier B, Hamtiaux L, Millet R, Poupaert JH, et al. Pharmacomodulations around the 4-oxo-1, 4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality. J Med Chem. 2007;50(22):5471–84.
Article
CAS
Google Scholar
Niedermeier S, Singethan K, Rohrer SG, Matz M, Kossner M, Diederich S, et al. A small-molecule inhibitor of Nipah virus envelope protein-mediated membrane fusion. J Med Chem. 2009;52(14):4257–65.
Article
CAS
Google Scholar